Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Youkyung Choi"'
Autor:
Jungreem Woo, Youkyung Choi
Publikováno v:
Pathogens, Vol 13, Iss 4, p 331 (2024)
The hepatitis C virus (HCV) infection affects 58 million people worldwide. In the United States, the incidence rate of acute hepatitis C has doubled since 2014; during 2021, this increased to 5% from 2020. Acute hepatitis C is defined by any symptom
Externí odkaz:
https://doaj.org/article/c2b37221d16f4093bf7c8fce1c15384a
Publikováno v:
Life, Vol 13, Iss 7, p 1527 (2023)
The hepatitis B virus (HBV) and hepatitis D virus (HDV) infections cause liver disease, including hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). HBV infection remains a major global health problem. In 2019, 296 million people were living w
Externí odkaz:
https://doaj.org/article/61bec4c113bc45e787bad79c85e6af35
Autor:
Martijn D. B. van de Garde, Suzan D. Pas, Gertine W. van Oord, Lucio Gama, Youkyung Choi, Robert A. de Man, Andre Boonstra, Thomas Vanwolleghem
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immunological determinants of viral persistence remain largely unexplored. We studied the antiviral potency of pegylated interferon-α (pegIFNα) agai
Externí odkaz:
https://doaj.org/article/92e4c668c29940759340cefbb3ea2515
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76501 (2013)
The relationships among micro RNA-122 (miR-122) expression in the liver, hepatitis C virus (HCV) replication and hepatic damage were analyzed in three chimpanzees observed for 180 days after inoculation with HCV genotype 1a. Levels of miR-122 in the
Externí odkaz:
https://doaj.org/article/f74a6220cde84a1bad21f35f192f80b9
Autor:
Youkyung Choi, Grace Sanghee Lee, Song Li, Jeong Woo Lee, Tonya Mixson-Hayden, Jungreem Woo, Dengning Xia, Mark R. Prausnitz, Saleem Kamili, Michael A. Purdy, Rania A. Tohme
Publikováno v:
Vaccine.
Autor:
Youkyung Choi, Saleem Kamili, Mark R. Prausnitz, Xiugen Zhang, Siobhán O'Connor, Maja Kodani, Monica B. Perez-Cuevas
Publikováno v:
J Infect Dis
Background This study evaluated dissolvable microneedle patch (dMNP) delivery of hepatitis B vaccine in rhesus macaques and provides evidence that dMNP delivery elicits seroprotective anti-HBs levels comparable with human seroprotection, potentially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a966dacdaf8bcac16e145dfc91f3fa
https://europepmc.org/articles/PMC6834072/
https://europepmc.org/articles/PMC6834072/
Publikováno v:
The Journal of infectious diseases. 220(6)
Publikováno v:
J Infect Dis
Background Secondary spread of hepatitis E virus (HEV) infection occurs often in endemic settings in developing countries. The host immune signatures contributing to protection against subsequent HEV reinfection are unknown. Methods Twelve seroconver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2a0d8931dcebe54ed463ef13d4cdf7
https://europepmc.org/articles/PMC8996334/
https://europepmc.org/articles/PMC8996334/
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0237618 (2020)
PLoS ONE
PLoS ONE
Hepatitis E virus (HEV) genotype 1 (gt1) and gt3 infections have distinct epidemiologic characteristics and genotype-specific molecular mechanisms of pathogenesis are not well characterized. Previously, we showed differences in immune response-relate
Autor:
Youkyung Choi, Lucio Gama, Robert A. de Man, Andre Boonstra, Gertine W. van Oord, Martijn D. B. van de Garde, Suzan D. Pas, Thomas Vanwolleghem
Publikováno v:
Scientific reports
Scientific Reports, 7:8267. Nature Publishing Group
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports, 7:8267. Nature Publishing Group
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Antiviral treatment options for chronic Hepatitis E Virus (HEV) infections are limited and immunological determinants of viral persistence remain largely unexplored. We studied the antiviral potency of pegylated interferon-α (pegIFNα) against HEV i